NewslettersPancreatic Cell NewsUncategorizedOzempic® 2.0 mg Approved in the US for the Treatment of Type 2 DiabetesBy Justin.choi - March 29, 20220230Novo Nordisk announced that the FDA has approved a 2.0 mg dose of Ozempic® a glucagon-like peptide-1 analogue for the treatment of adults with type 2 diabetes.[Full Journal Title] 6445212 BBBBBBBB items 1 apa 0 default asc 1 173422 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Press Release